<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03894072</url>
  </required_header>
  <id_info>
    <org_study_id>Si066/2019</org_study_id>
    <nct_id>NCT03894072</nct_id>
  </id_info>
  <brief_title>HFHO vs CPAP During Thoracic Surgery</brief_title>
  <official_title>Effect of High Flow Humidified Oxygen on Non-ventilated Lung During Thoracic Surgery: a Cross-over Study Compared With Conventional CPAP (Continuous Positive Airway Pressure)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single institutional cross-over study design to compare between high flow humidified oxygen
      (HFHO) device versus conventional CPAP for non-ventilated lung during thoracic surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that HFHO may be an alternative tool to supply oxygen to
      non-ventilated lung during one lung ventilation. CPAP can improve oxygenation at a cost of
      lung hyperinflation which is an unwanted condition during thoracic surgery especially the
      video-assisted one.

      Recruiting adult patients who undergo lung surgeries that requires one-lung ventilation.
      Exclusion criteria include the followings:-

        1. Emergency case.

        2. Patients with severe COPD(Chronic Obstructive Pulmonary Diseases).

        3. Patients with moderate baseline hypoxemia (SpO2 &lt; 90% on room air).

        4. Patients with severe hemoptysis.

        5. Patients with upper or lower airway abnormalities.

        6. Patients undergo pulmonary lavage.

        7. Patients with known pulmonary hypertension.

        8. Patients with known pulmonary/tracheobronchial infections.

        9. Patients with suspected difficult airway.

       10. Patients with BMI over 35.

       11. Pregnant patients.

      Following a standard anesthetic practice. All participants will receive an intravenous based
      anesthetic with or without regional blocks. The appropriate sized double lumen endobronchial
      tube will be placed and fiberoptic bronchoscope is used to verify a proper position. Patient
      will also get an arterial line for frequent ABG (Arterial Blood Gases) samplings.

      Computer generated randomization will divide patients into 2 groups. Baseline ABG will be
      drawn. After one lung ventilation commenced for 20 minutes, the 2nd ABG will be drawn, the
      surgeon who was blinded to the intervention will evaluate the quality of lung collapse using
      5-point Likert scale. Then, patients will either receive a CPAP or HFHO (depends on
      randomization) for 20 minutes. Up on 1st intervention completion, the 3rd ABG and lung
      collapse evaluation will be performed.

      Following the first intervention, the non-ventilated lung will be suctioned out and wait for
      20 minutes. Another ABG will be sampled at this point.

      The patient will receive the 2nd alternative intervention (CPAP or HFHO- depend on their
      randomization) for 20 minutes. The final ABG and lung collapse evaluation will be performed.

      If any severe hypoxemia/ hypercarbia and marked violation of protocol occurs. Patients will
      be excluded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>HFHO-CPAP CPAP-HFHO</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with improved oxygenation.</measure>
    <time_frame>20 minutes</time_frame>
    <description>Improvement of gas exchanges by arterial blood gases</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of lung collapsed.</measure>
    <time_frame>20 minutes</time_frame>
    <description>Lung collapse quality by surgeon using 5-point Likert scale where 5 = very good, 4= good, 3 = acceptable, 2 = poor and 1= very poor</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Hypoxaemia During Surgery</condition>
  <condition>Lung Hyperinflation</condition>
  <arm_group>
    <arm_group_label>HFHO-CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will have HFHO before CPAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP-HFHO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will have CPAP and then HFHO</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>Conventional CPAP</description>
    <arm_group_label>CPAP-HFHO</arm_group_label>
    <arm_group_label>HFHO-CPAP</arm_group_label>
    <other_name>Mallinkrodt CPAP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HFHO</intervention_name>
    <description>A device that can provide heated humidified oxygen up to 30-60 liter per minute, FiO2 (fraction of inspired oxygen) 0.21-0.95</description>
    <arm_group_label>CPAP-HFHO</arm_group_label>
    <arm_group_label>HFHO-CPAP</arm_group_label>
    <other_name>Optiflow, Airvo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult &gt; 18 years of age undergoes lung surgeries that required one-lung
             ventilation

        Exclusion Criteria:

          -  emergency case

          -  severe COPD

          -  moderate baseline hypoxemia

          -  pulmonary hypertension

          -  difficult upper/lower airway

          -  BMI &gt; 35

          -  severe pneumonia

          -  bronchial lavage

          -  massive hemoptysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prasert Sawasdiwipachai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Prasert Sawasdiwipachai, MD</last_name>
    <phone>+66874147409</phone>
    <email>prasert.saw@mahidol.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ratchaya Weerayutwattana, MD</last_name>
    <phone>0897566687</phone>
    <email>ratchaya.wr@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prasert Sawasdiwipachai, MD</last_name>
      <phone>6624113256</phone>
      <email>prasert.saw@mahidol.ac.th</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 27, 2019</study_first_submitted>
  <study_first_submitted_qc>March 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2019</study_first_posted>
  <last_update_submitted>March 30, 2019</last_update_submitted>
  <last_update_submitted_qc>March 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Prasert Sawasdiwipachai</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>High flow oxygen device, HFHO, CPAP, One-lung ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Not yet decided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

